NeuroGen aims to repair brain lesions through minimally-invasive cell therapy to restore brain function. NeuroGen is a biotech start-up that aims to address severe socioeconomic, and environmental impacts caused by brain lesions and subsequent lifetime disabilities across the globe. Traumatic brain injuries (TBIs) caused by workplace/road accidents, childhood brain injuries and domestic violence are few of the many possible causes of brain injuries that could happen unexpectedly leading to a lifetime disability. Few pharmaceutical therapies alongside physical therapy are available to support the management of the condition but without a long-term solution. NeuroGen's future envisions expanding to other brain injuries caused by stroke, neurodegenerative disorders (Alzheimer's and Parkinson's diseases), and neurodevelopmental disorders (Autism). Our aim is to build a future where brain injuries are no longer a concern and bring hope to people's lives “because everyone deserves a healthy brain”.
